77 results
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
24 Jun 24
Material Modifications to Rights of Security Holders
4:23pm
relating to a series of the Company’s preferred stock, consisting of 8,950 authorized shares of preferred stock, classified as Series G Convertible
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
relating to a series of the Company’s preferred stock, consisting of 8,950 authorized shares of preferred stock, classified as Series G Convertible
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
, in connection with United States generally accepted accounting principles, consistently applied for the periods covered thereby, is classified
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured
8-K
EX-3.1
tcxgjz4
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.2
qxj8c64r8z
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.3
v4ivjmetds zt
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.1
61jvgmkr8ku09lgl
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
nhsi jzywy1pfer
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-3.1
onyjv5
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm